Work

A breast cancer patient developed γδ T-cell acute lymphoblastic leukemia after chemotherapy: a case report with literary review

Year: 2025

Type: article

Abstract: Gamma delta T-cell (γδ T-cell) acute lymphoblastic leukemia(γδ T-ALL) is rare and aggressive, but secondary γδ T-ALL following breast cancer is more rare. Our case presents a patient with breast cancer, received surgical treatment and chemotherapy consisting of epirubicin and cyclophosphamide. Three years later, the patient got secondary γδ T-ALL. The chemotherapeutic agents had a significant effect on the breast cancer patient, who has an increased risk of secondary γδ T-ALL.

Source: Annals of Hematology

DOI: 10.1007/s00277-025-06690-7

Authors: Xiaofeng Yang, Xiaofeng Yang, Zhihua Zhang, Xue Wu, Xinhong Yang, Xinhong Yang

Institutions: Chengde Medical University, Affiliated Hospital of Chengde Medical College

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,590